Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

Presentation TCT 2025

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

Presenter: Azeem Latib

October 28, 2025

Presentation TCT 2025

TCT 973: A Systematic Review and Meta-analysis of Intra-Aortic Balloon Pump compared with Medical Therapy alone or with Left-Ventricular Assist Device for Cardiogenic Shock

Presenter: Aleena Usman

October 27, 2025

Presentation TCT 2025

Patient-Specific Diagnostic, Monitoring & Predictive Devices for Structural Heart Healthcare (Prognics)

Presenter: Mohammad Sarraf

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

Presenter: Sheldon E. Litwin

October 25, 2025

Presentation TCT 2025

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

Presenter: Daniel Burkhoff

October 25, 2025

Presentation TCT 2025

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

Presenter: Michal Kosowski

October 25, 2025

Presentation TCT 2024

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Presenter: Eric Rytkin

October 29, 2024

Presentation TCT 2023

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Presenter: Clyde Yancy

October 24, 2023

Presentation TCT 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Presentation TCT 2022

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Reducer Device Overview and Mechanism of Action

Presenter: Allen Jeremias

September 18, 2022

Presentation TCT 2022

Future Vision: Clinical and Technology Requirements for the Successful Development of Transcatheter Tricuspid Therapy Programs

Presenter: Azeem Latib

September 17, 2022

Presentation TCT 2022

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Presenter: David Cohen

September 17, 2022

Presentation TCT 2022

Physiologic and Hemodynamic Parameters Influencing Device Selection and Clinical Outcomes

Presenter: Neil Fam

September 17, 2022

Advertisement

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

TCT 973: A Systematic Review and Meta-analysis of Intra-Aortic Balloon Pump compared with Medical Therapy alone or with Left-Ventricular Assist Device for Cardiogenic Shock

Patient-Specific Diagnostic, Monitoring & Predictive Devices for Structural Heart Healthcare (Prognics)

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

GLP-1 and GIP Antagonism on HF Therapy: Implications for Device Therapy

ARS 29: At the Crossroads of Medical and Device Therapy in HF Treatment

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

State-of-the-Art Lecture: Future Device Therapies in PE

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

CDT: New Devices, Drugs, and Duration?

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Reducer Device Overview and Mechanism of Action

Future Vision: Clinical and Technology Requirements for the Successful Development of Transcatheter Tricuspid Therapy Programs

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Physiologic and Hemodynamic Parameters Influencing Device Selection and Clinical Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content